KORU Medical Systems Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2020

Share-based Payment Arrangement [Abstract]

Schedule of fair value of the stock options granted Black-Scholes option valuation model

The risk-free interest rate was selected based upon yields of the U.S. Treasury issues with a term equal to the expected life of the option being valued.


	March 31,
	2020		2019

Dividend yield		—		0.00%
Expected Volatility		—		59.4%-60.3%
Weighted-average volatility		—		—
Expected dividends		—		—
Expected term (in years)		—		10
Risk-free rate		—		2.64-2.72%

Schedule of stock option plan

The following table summarizes the status of the Plan with respect to time based stock options:


	Three Months Ended March 31,
	2020			2019
	Shares	Weighted Average Exercise Price		Shares		Weighted Average Exercise Price

Outstanding at January 1	3,647,000	$	1.32		2,419,000	$	1.00
Granted	—	$	—		1,050,000	$	1.57
Exercised	175,000	$	0.49		—	$	—
Forfeited	—	$	—		—	$	—
Outstanding at March 31	3,472,000	$	1.36		3,469,000	$	1.17
Options exercisable at March 31	1,306,635	$	1.05		828,219	$	0.58
Weighted average fair value of options granted during the period	—	$	—		—	$	1.10
Stock-based compensation expense		$	175,239			$	121,875

Schedule of information pertaining to options outstanding

The following table presents information pertaining to options outstanding at March 31, 2020:


Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price

$0.38-$3.15	3,472,000	6.4 years	$	1.36	1,306,635	$	1.05

Schedule of performance base share options

The risk-free interest rate was selected based upon yields of the U.S. Treasury issues with a term equal to the expected life of the option being valued.


	March 31,
	2020		2019

Dividend yield		—		—
Expected Volatility		—		—
Weighted-average volatility		—		—
Expected dividends		—		—
Expected term (in years)		—		—
Risk-free rate		—		—

Schedule of performance base options outstanding

The following table summarizes the status of the Plan with respect to performance based stock options:


	Three months Ended March 31,
	2020			2019
	Shares	Weighted Average Exercise Price		Shares		Weighted Average Exercise Price

Outstanding at January 1	1,000,000	$	1.70		—	$	—
Granted	—	$	—		—	$	—
Exercised	—	$	—		—	$	—
Forfeited	—	$	—		—	$	—
Outstanding at March 31	1,000,000	$	1.70		—	$	—
Options exercisable at March 31	—	$	—		—	$	—
Weighted average fair value of options granted during the period	—	$	—		—	$	—
Stock-based compensation expense	—	$	125,727		—	$	—

Schedule of information pertaining to performance base options outstanding

The following table presents information pertaining to performance based options outstanding at March 31, 2020:


Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price

$1.70	1,000,000	9.2 years	$	1.70	—	$	—